Medipal Holdings (7459) · FactContinued shareholding of treasury stock
Takeda Pharmaceutical Company ceases to be a major shareholder
First written in FY2019-Q1. . Latest entry: FY2021-Q3.
4entries
4years
0from disclosures
How it moved
Same theme, other companies
Corporate Shareholders Becoming or Ceasing to Be Major ShareholdersA theme 67 companies write about · 1 as a headwind · 0 as a tailwind
25 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 67 companies compared. The sentences above are computed from all 67.Full recordFilings, disclosures and news, newest first
- FY2021-Q3Continued shareholding of treasury stockAnnual report
「Common shares with full voting rights (excluding treasury shares, etc.): 34,561,300」
As of 31 December 2020, the company held 34,561,300 treasury shares, representing 14.13% of total issued shares. The status of holdings after the existing treasury-share acquisition can be confirmed. - FY2020-Q1Intention of the largest shareholder to sell its holdingsAnnual report
「Against this backdrop, in early June 2019, we were informed by Takeda Pharmaceutical Company Limited ("Takeda"), our largest shareholder, that it intended to sell its holdings of our common shares.」
Following its previous re-listing under Major Shareholders, Takeda informed the company of its intention to sell its holdings as the largest shareholder. The company considered acquiring those shares as treasury shares and decided to launch a tender offer. - FY2019-Q2Re-listed as a major shareholderAnnual report
「Takeda Pharmaceutical Company Limited 4-1, Doshomachi 4-chome, Chuo-ku, Osaka 11,400 5.12」
As of 30 September 2018, Takeda Pharmaceutical was listed among the major shareholders as holding 11,400 thousand shares, or 5.12%. The filing provides no explanation of this status following the statement in the previous filing that it had ceased to be a major shareholder. - FY2019-Q1First statedAnnual report
「The large shareholding report (change report) filed by Takeda Pharmaceutical Company Limited on 22 June 2018 stated that it had sold the company's common shares. Accordingly, Takeda Pharmaceutical Company Limited ceased to be a major shareholder of the company.」
The company disclosed that Takeda Pharmaceutical had sold its common shares and ceased to be a major shareholder.